Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 209853
Company: APOTEX
Company: APOTEX
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CLOBAZAM | CLOBAZAM | 10MG | TABLET;ORAL | Discontinued | None | No | No |
CLOBAZAM | CLOBAZAM | 20MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/09/2020 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
05/15/2024 | SUPPL-3 | Labeling-Package Insert |
Label is not available on this site. |
||
03/22/2023 | SUPPL-2 | Labeling-Medication Guide, Labeling-Package Insert |
Label is not available on this site. |
||
10/25/2021 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |